Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
ProteoGenix SAS is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:France
Founded:2003
Employees:1,942
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Europe
Regulatory Approvals
Drug Approval 8ZQYG6
PMDA · #APR-9X3AJ41K · 2018-05-01
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-5VNBNGFQ
Issued: 2020-06-10
Expires: 2025-02-12
WHO GMP
World Health Organization
Cert #: CERT-0OL5APNC
Issued: 2020-07-05
Expires: 2025-09-20
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-DEMRFGA7
Issued: 2020-04-22
Expires: 2025-02-10
Health Canada GMP
Health Canada
Cert #: CERT-1GQPC2XQ
Issued: 2020-11-09
Expires: 2025-01-26
Loading CDMO intelligence...
Key facts about ProteoGenix SAS
- ProteoGenix SAS is headquartered in France.
- ProteoGenix SAS was founded in 2003.
- ProteoGenix SAS has 1,942 employees.
- ProteoGenix SAS's capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like ProteoGenix SAS
Directory pages this company appears in, each with the full list of matching manufacturers.